A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)

Clinical trial NCT07264634 · RECRUITING

Trial details

NCT number: NCT07264634
Sponsor: Ascendis Pharma A/S
Status: RECRUITING
Study type: OBSERVATIONAL

Hypoparathyroidism

Start date: 2026-03-19
Primary completion: 2027-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.